Prosecution Insights
Last updated: August 15, 2026
Application No. 17/992,102

Oral Care Compositions and Methods for the Same

Final Rejection §101§103§112
Filed
Nov 22, 2022
Priority
Nov 23, 2021 — provisional 63/282,229
Examiner
KAMM, JUDITH MARIE
Art Unit
1611
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Colgate-Palmolive Company
OA Round
6 (Final)
46%
Grant Probability
Moderate
7-8
OA Rounds
2m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 46% of resolved cases
46%
Career Allowance Rate
27 granted / 59 resolved
-14.2% vs TC avg
Strong +59% interview lift
Without
With
+59.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 11m
Avg Prosecution
39 currently pending
Career history
108
Total Applications
across all art units

Statute-Specific Performance

§101
2.5%
-37.5% vs TC avg
§103
41.6%
+1.6% vs TC avg
§102
10.9%
-29.1% vs TC avg
§112
27.3%
-12.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 59 resolved cases

Office Action

§101 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Withdrawn Objections/Rejections The previous rejections of claims 1-3, 10, 12-15, and 20-32 under 35 USC § 112(b) are withdrawn in view of the claim amendments. Claim Status Applicant’s amendments and arguments filed 03/12/2026 have been fully considered. Rejections and/or objections not reiterated from previous office actions are hereby withdrawn. The following rejections and/or objections are either reiterated or newly applied. They constitute the complete set presently being applied to the instant application. Claims 4-9, 11, and 16-19 are cancelled. Claims 1-3, 10, 12-15, and 20-32 are pending and under current examination. Claim Interpretation For purposes of examination and applying prior art, the term “about” is being interpreted as defined in the specification at paragraph [0025], “It should also be appreciated that the term "about," as used herein, in conjunction with a numeral refers to a value that may be± 0.01 % (inclusive), ± 0.1 % (inclusive), ± 0.5% (inclusive), ± 1 % (inclusive) of that numeral, ± 2% (inclusive) of that numeral, ± 3% (inclusive) of that numeral, ± 5% (inclusive) of that numeral, ± 10% (inclusive) of that numeral, or ± 15% (inclusive) of that numeral.” That is, numerals modified by the term “about” are interpreted as being inclusive of the numeral ± 15%. New Rejections Necessitated by Claim Amendments Claim Rejections - 35 USC § 112(b) The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. Claims 12-14 are rejected under 35 U.S.C. 112(b) as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor regards as the invention. Claim 1 recites an oral care composition comprising an orally acceptable vehicle comprising a flavorant. Claim 12, which depends from claim 1, recites (emphasis added) “wherein the orally acceptable vehicle further comprises one or more of a humectant,…a flavorant, or combinations thereof”. It is unclear if the “further” flavorant of claim 12 is intended to require a second flavorant in addition to the flavorant of claim 1 or not. It is suggested that Applicant remove the recitation of “a flavorant” from instant claim 12. Claims 13-14 are rejected under 35 U.S.C. 112(b) by virtue of their dependency on indefinite claim 12 and failure to cure the deficiency noted above. It is further unclear if “the flavorant” recited in instant claim 14 refers to the flavorant recited in claim 1 or another “further” flavorant of claim 12. Rejections Maintained, Slightly Modified to Address Amended Claims Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-3, 10, 12-15, and 20-32 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a natural phenomenon without significantly more. In accordance with MPEP § 2106, claims found to recite statutory subject matter (in the instant case, a composition of matter; Step 1: YES) are then analyzed to determine if the claims recite any concepts that equate to an abstract idea, law of nature, or natural phenomenon (Step 2A, Prong One). In the instant application, the claims are directed to: An oral care composition, comprising: an orally acceptable vehicle; wherein the orally acceptable vehicle comprises a source of zinc ion present in an amount of from about 0.01 wt% to about 5 wt% based on the total weight of the composition and a flavorant; one or more fructans; and one or more thickening agents, wherein the thickening agents are present in an amount effective to prevent interaction-induced crystallization of the one or more fructans with the orally acceptable vehicle upon exposure to an accelerated aging condition, said condition comprising exposure to temperatures at about 0°C or less, and wherein the weight ratio of the one or more fructans to the one or more thickening agents is from about 0.1:1 to about 10:1. The claims further recite that the one or more fructans comprise inulin wherein the inulin comprises a degree of polymerization of from 2 to less than 10, the one or more thickening agents comprises xanthan gum, and the orally acceptable vehicle comprises one or more of a humectant, a solvent, a pH modifying agent, a fluoride ion source, a zinc ion source, a desensitizing agent, a flavorant, or combinations thereof wherein the humectant comprises one or more of xylitol, glycerin, sorbitol, trimethylene glycol, or a combination thereof and wherein the flavorant comprises menthol. The claims are directed to a judicial exception such as a natural phenomenon (e.g., product of nature) as the only compositional requirement set forth in the instant claims is that the composition comprises a combination of naturally occurring ingredients. As evidenced by Cosmetic Ingredient Review (“Safety Assessment of Zinc Salts as Used in Cosmetics”; of record), zinc salts (a source of zinc ions) occur naturally in some seafood, red meat, whole grains, and human tissues and body fluids (pg. 4, “Natural Occurrence”); zinc salts are used in oral care products (pg. 4, bottom paragraph). As evidenced by Chen et al. (“Effects of inulin with different polymerization degrees on the structural and gelation properties of potato protein”; of record), inulin is a natural fructan joined by β (2→1) glycosidic bonds with a terminal β-glucose unit; the degree of polymerization of inulin varies from 2 to 60 depending on the plant source and isolation or production methods (pg. 1, “Introduction”, paragraph 3). As evidenced by Villines (“All you need to know about xanthan gum”; of record), xanthan gum is a polysaccharide, a type of sugar that is made from a bacteria called Xanthomonas campestris (pg. 1, paragraph 2). As evidenced by WebMD (“Xylitol-Uses, Side Effects, and More”; of record), xylitol is a natural sugar alcohol found in plants (“Overview”, paragraph 1). As evidenced by American Lung Association (“What Is Menthol?”; of record), menthol is a chemical naturally found in peppermint and other mint plants (pg. 1, paragraph 1). In view of the above, all of the components recited in instant claims 1-3, 10, 12-15, and 20-32 are naturally occurring. MPEP 2106.04(c) states that the markedly different characteristics analysis is part of Step 2A Prong One: “Where the claim is to a nature-based product produced by combining multiple components (e.g., a claim to "a probiotic composition comprising a mixture of Lactobacillus and milk"), the markedly different characteristics analysis should be applied to the resultant nature-based combination, rather than its component parts.” Further, from MPEP 2106.04(c): “The markedly different characteristics analysis compares the nature-based product limitation to its naturally occurring counterpart in its natural state. Markedly different characteristics can be expressed as the product’s structure, function, and/or other properties, and are evaluated based on what is recited in the claim on a case-by-case basis. If the analysis indicates that a nature-based product limitation does not exhibit markedly different characteristics, then that limitation is a product of nature exception. If the analysis indicates that a nature-based product limitation does have markedly different characteristics, then that limitation is not a product of nature exception.” The guidelines for performing the markedly different characteristics analysis, include (a) selecting the appropriate naturally occurring counterpart(s) to the nature-based product limitation, (b) identifying appropriate characteristics for analysis, and (c) evaluating characteristics to determine whether they are "markedly different". Regarding (a), MPEP 2106.04(c) recites: “When the nature-based product is a combination produced from multiple components, the closest counterpart may be the individual nature-based components of the combination. For example, assume that applicant claims an inoculant comprising a mixture of bacteria from different species, e.g., some bacteria of species E and some bacteria of species F. Because there is no counterpart mixture in nature, the closest counterparts to the claimed mixture are the individual components of the mixture, i.e., each naturally occurring species by itself. See, e.g., Funk Bros., 333 U.S. at 130, 76 USPQ at 281 (comparing claimed mixture of bacterial species to each species as it occurs in nature); Ambry Genetics, 774 F.3d at 760, 113 USPQ2d at 1244 (although claimed as a pair, individual primer molecules were compared to corresponding segments of naturally occurring gene sequence); In re Bhagat, 726 Fed. Appx. 772, 778-79 (Fed. Cir. 2018) (non-precedential) (comparing claimed mixture of lipids with particular lipid profile to "naturally occurring lipid profiles of walnut oil and olive oil").” In the instant case, the closest counterparts to the claimed mixture are the individual components of the mixture. Regarding (b), MPEP 2106.04(c) recites: “Appropriate characteristics must be possessed by the claimed product, because it is the claim that must define the invention to be patented. Cf. Roslin, 750 F.3d at 1338, 110 USPQ2d at 1673 (unclaimed characteristics could not contribute to eligibility). Examiners can identify the characteristics possessed by the claimed product by looking at what is recited in the claim language and encompassed within the broadest reasonable interpretation of the nature-based product. In some claims, a characteristic may be explicitly recited.” In the instant case, the claims are directed to a composition with the characteristic that the one or more thickening agents are effective to prevent interaction-induced crystallization of the one or more fructans with the orally acceptable vehicle upon exposure to temperatures at about 0 °C or less (see instant claim 1) and exposure to a temperature of about -10 °C (see instant claim 32). The claims further recite the characteristic that the one or more fructans are effective to treat or prevent oral malodor (see instant claim 21), and the one or more thickening agents are effective to modify the viscosity of the composition (see instant claim 23). Regarding (c), MPEP 2106.04(c)recites: “The final step in the markedly different characteristics analysis is to compare the characteristics of the claimed nature-based product to its naturally occurring counterpart in its natural state, in order to determine whether the characteristics of the claimed product are markedly different. The courts have emphasized that to show a marked difference, a characteristic must be changed as compared to nature, and cannot be an inherent or innate characteristic of the naturally occurring counterpart or an incidental change in a characteristic of the naturally occurring counterpart. Myriad, 569 U.S. at 580, 106 USPQ2d at 1974-75. Thus, in order to be markedly different, the inventor must have caused the claimed product to possess at least one characteristic that is different from that of the counterpart. If there is no change in any characteristic, the claimed product lacks markedly different characteristics, and is a product of nature exception. If there is a change in at least one characteristic as compared to the counterpart, and the change came about or was produced by the inventor’s efforts or influences, then the change will generally be considered a markedly different characteristic such that the claimed product is not a product of nature exception.” As evidenced by Villines, xanthan gum serves a primary purpose as a thickening agent (pg. 5, “What is xanthan gum used for?”), indicating that xanthan gum is capable of modifying the viscosity of a composition. As evidenced by Deosen (“Application of Water Solubility of Xanthan Gum in Food Processing”; of record), xanthan gum has good stability to temperature (see pg. 1, second paragraph from bottom), can act as a stabilizing emulsifier in the range of -18~100 °C, can control the growth rate of ice crystals, and can inhibit the increase of ice crystals (see pg. 2, “2. Application of xanthan gum in frozen foods”), indicating that xanthan gum is capable of preventing crystallization upon exposure to temperatures of 0 °C or less and exposure to a temperature of about -10 °C. As evidenced by Doran et al. (“A clinical study on the effect of the prebiotic inulin in the control of oral malodour”; of record), after rinsing with inulin, a reduction in tongue pH concomitant with a reduction of breath odor was observed (pg. 161, “Discussion” paragraph 1), indicating that inulin is capable of treating oral malodor. As such, there is no indication of record that the components of the claimed composition have been structurally or functionally changed from their naturally occurring counterparts or that their combination has imparted a markedly different characteristic to the composition. Consequently, the claimed composition lacks markedly different characteristics and is a product of nature exception (Step 2A, Prong 1: YES). Claims found to recite a judicial exception under Step 2A, Prong 1 are then further analyzed to determine if the claims as a whole integrate the recited judicial exception into a practical application or not (Step 2A, Prong 2). This judicial exception is not integrated into a practical application because there are no additional elements recited in the claims beyond the judicial exception. From MPEP 2106.04(d): “Because a judicial exception alone is not eligible subject matter, if there are no additional claim elements besides the judicial exception, or if the additional claim elements merely recite another judicial exception, that is insufficient to integrate the judicial exception into a practical application.” (Step 2A, Prong 2: NO). Claims found to be directed to a judicial exception are then further evaluated to determine if the claims recite an inventive concept that provides significantly more than the judicial exception itself (Step 2B). The claims do not recite anything else, compositionally or structurally, which provides an inventive concept that departs from merely reciting a composition containing all naturally occurring components, the composition having properties that are consistent with the naturally occurring counterparts of the components of the composition. The recitation of specific amounts and ratios of ingredients does not appear to add significantly more. There is no evidence that suggests that the properties claimed would not be achieved by simply combining the claimed components. Merely adjusting the amounts and ratios of components would not rise to substantially more than the judicial exception (Step 2B: NO). Therefore, the claims are not patent eligible subject matter under 35 USC § 101. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-2, 10, 12-15 and 21-32 are rejected under 35 U.S.C. 103 as being unpatentable over Schapiro et al. (US 9,387969 B2, patent issued July 12, 2016, included in IDS submitted 11/22/2022), hereafter “Schapiro” as evidenced by Deosen (“Application of Water Solubility of Xanthan Gum in Food Processing” May 12, 2021, https://web.archive.org/web/20210512120120/https://www.deosen.com/application-of-water-solubility-of-xanthan-gum-in-food-processing.html; of record) in view of Doran et al. (“A clinical study on the effect of the prebiotic inulin in the control of oral malodour” Microbial Ecology in Health and Disease, 2007, 19, 158-163; of record), hereafter “Doran”, Tom’s of Maine (“Spearmint Natural Prebiotic Fluoride Toothpaste”, March 2020, Mintel Database GNPDAN:7501575; included in IDS submitted 06/06/2023), and Rege et al. (US 2015/0313813 A1, published November 5th, 2015; of record), hereafter “Rege”. Regarding instant claim 1, Shapiro teaches a toothpaste composition including different combinations of ingredients including one or more fructans (specifically inulin) and one or more thickening agents (konjac gum and/or agar-agar, xanthan, tara gum, gum Arabic, etc.) combined in an orally acceptable vehicle (water) (abstract, examples 2 and 3). Schapiro further teaches that the flavor of the compositions may be altered by the addition of natural and/or artificial flavorants (column 5, lines 50-53). The specification of the instant invention states that "the thickening agents may be present in an amount effective to stabilize or facilitate the stabilization of the one or more fructans, preferably, the thickening agents may be present in an amount effective to stabilize or facilitate the stabilization of the one or more fructans upon exposure to an accelerated aging condition, more preferably, the accelerated aging condition may include exposure to temperatures at about 0°C or less. In at least one implementation, the thickening agents may be present in an amount of from about 0.1 wt% to about 10 wt%" (paragraphs [0013]-[0014]). As further noted in the instant specification, thickening agents prevent formation of crystallization of inulin (paragraph [0028]). This wt.% of thickening agents present is therefore interpreted to be an amount effective to stabilize or facilitate the stabilization of the one or more fructans. Schapiro provides, in alternative example 2, an example where inulin is present from 0.2-0.7 wt.% and a combination of konjac gum and the thickeners xanthan/guar are present from 1.15-4.55 wt.%; this falls within the range cited in the instant specification as an amount effective to stabilize or facilitate the stabilization of the one or more fructans upon exposure to an accelerated aging conditions including exposure to temperatures at about 0°C or less. This further provides a range of weight ratios of fructan to thickening agent from 0.04:1 to 0.6:1, overlapping the range of instant claim 1. From MPEP 2144.05: “In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990).” Given that Schapiro teaches xanthan/guar and konjac gum thickeners from 1.15-4.55% with inulin, the thickeners would necessarily prevent interaction-induced crystallization of inulin upon exposure to an accelerated aging condition comprising exposure to temperatures at about 0°C or less, absent evidence to the contrary. Further, as evidenced by Deosen, xanthan gum has good stability to temperature (see pg. 1, second paragraph from bottom), can act as a stabilizing emulsifier in the range of -18~100 °C, can control the growth rate of ice crystals, and can inhibit the increase of ice crystals (see pg. 2, “2. Application of xanthan gum in frozen foods”), indicating to one of ordinary skill in the art that xanthan gum is capable of preventing crystallization upon exposure to temperatures of 0 °C or less. Regarding instant claim 2, as described above, the toothpaste composition of Schapiro in examples 2 and 3 can comprise inulin. Regarding instant claim 10, the specification of the instant invention states that "the fructans and the thickening agents may be present in a weight ratio sufficient to stabilize or facilitate the stabilization of the fructans. In at least one implementation, the weight ratio of the fructans to the thickening agents may be from about 0.1: 1 to about 10: 1..." (paragraphs [0015]-[0016]); this range of weight ratios is therefore interpreted to be sufficient to stabilize or facilitate the stabilization of the fructans. As noted above, Schapiro provides, in alternative example 2, an example where inulin is present from 0.2-0.7 wt.% and a combination of konjac gum and xanthan/guar are present from 1.15-4.55 wt.%; this provides a range of weight ratios of fructan to thickening agent from 0.04:1 to 0.6:1, overlapping the range of instant claim 1. From MPEP 2144.05: “In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990).” Regarding claims 12-13, the composition of Schapiro further comprises the humectant of xylitol (examples 1-3). Schapiro further teaches that the flavor of the compositions may be altered by the addition of natural and/or artificial flavorants (column 5, lines 50-53). Regarding claim 15, Schapiro further provides a method of making the toothpaste compositions described above; notably, column 4, step 5 describes mixing (contacting) the components of example 2. As inulin is provided as an alternative to tara gum in this example, the active method step of claim 15 is suggested. Contacting the components would necessarily result in the property of preventing, inhibiting, or mitigating crystallization of the fructan, absent evidence to the contrary. Regarding instant claims 21-22, the specification of the instant invention states that "the one or more fructans may be present in an amount effective to treat, prevent, or otherwise inhibit oral malodor. For example, the one or more fructans may be present in an amount from about 0.01 wt.% to about 10 wt.% ... " (paragraph [0035]); this wt.% of fructans present is therefore interpreted to be an amount effective to treat, prevent, or otherwise inhibit oral malodor. Schapiro provides in alternative example 2 a composition that comprises 0.2-0.7% inulin by weight, overlapping the range of instant claim 22. From MPEP 2144.05: “In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990).” Regarding instant claim 23, the composition of Schapiro is directed to a toothpaste product comprising different combinations of ingredients including one or more polymer thickening agents (konjac gum and/or agar-agar, xanthan, tara gum, gum Arabic, etc.) that maintains its shape (abstract); thus, the viscosity of the toothpaste has been modified, and the thickening agents are considered to be in an amount present to modify the viscosity. Regarding instant claims 24-27 Schapiro teaches that the toothpaste composition "includes different combinations of konjac gum and/or agar-agar, alginates, gelatin, pectin, xanthan, tara gum, gum arabic, carrageenan, celluloses, gellan gum, guar gum, inulin, konjac, locust bean gum, pectin, tragacanth, xanthan ... "(abstract). Examples 2 and 3 comprise the polysaccharide gum xanthan. Regarding instant claims 28-29, Schapiro provides, in alternative example 2, an example where inulin is present from 0.2-0.7 wt.% and a combination of konjac gum and xanthan/guar are present from 1.15-4.55 wt.%, overlapping the claimed ranges. From MPEP 2144.05: “In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990).” Regarding instant claim 30, Schapiro teaches that tara gum can be present in the composition from 0.1 to 0.5% by weight in the toothpaste composition (Example 1), and further suggests that inulin can act as an alternative ingredient to tara gum in such compositions (Examples 2 and 3). From these teachings, it would have been prima facie obvious to one of ordinary skill in the art that amounts of inulin from 0.1 to 0.5% by weight are suitable for use in the toothpaste compositions of Schapiro, overlapping the range of the instant claim. From MPEP 2144.05: “In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990).” Regarding instant claim 31, Schapiro teaches water present from 41-54% by weight in the compositions (Examples 1-3). This overlaps the recited range of water (about 60 wt% being inclusive of 60 wt% ± 15%, or 51-69 wt%). From MPEP 2144.05: “In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990).” Regarding instant claim 32, as noted above, Schapiro provides, in alternative example 2, an example where inulin is present from 0.2-0.7 wt.% and a combination of konjac gum and the thickeners xanthan/guar are present from 1.15-4.55 wt.%; this falls within the range cited in the instant specification as an amount effective to stabilize or facilitate the stabilization of the one or more fructans upon exposure to an accelerated aging conditions including exposure to temperatures at about 0°C or less (which is inclusive of temperatures of about -10 °C). Additionally, as evidenced by Deosen, xanthan gum has good stability to temperature (see pg. 1, second paragraph from bottom), can act as a stabilizing emulsifier in the range of -18~100 °C, can control the growth rate of ice crystals, and can inhibit the increase of ice crystals (see pg. 2, “2. Application of xanthan gum in frozen foods”). While inulin is provided as an alternative to tara gum in the examples of Schapiro, Schapiro does not specifically exemplify a composition comprising inulin or the active method step of contacting inulin with the orally acceptable vehicle and the thickening agents. Schapiro does not teach that the oral care composition comprises a source of a zinc ion present in an amount of from about 0.01 wt% to about 5 wt% based on the total weight of the composition. Schapiro does not teach the limitation of instant claim 14 that the flavorant comprises menthol. Doran teaches that oral care rinses comprising the prebiotic inulin may provide a method for the control of oral malodour (Abstract), particularly through the ecological control of microorganisms in the mouth (Introduction) and maintaining the natural balance of the oral microflora (pg. 162, column 2, paragraph 4). Doran teaches that after rinsing with inulin, a reduction in tongue pH concomitant with a reduction of breath odor was observed (pg. 161, “Discussion” paragraph 1). Tom’s of Maine teaches a commercial prebiotic toothpaste that comprises inulin, the thickeners of xanthan gum and carrageenan, and zinc citrate (pg. 2, “Ingredients”) which is taught to help support good bacteria and maintain a healthy balance and freshen breath (pg. 1, “Product Description”). Rege teaches oral care compositions comprising from about 0.05 to about 5% by weight of a zinc ion source (abstract, claim 1) wherein the zinc ion source is zinc citrate (claims 2 and 12; paragraph [0011]). The compositions can comprise a viscosity modifying agent such as xanthan gum (see paragraph [0023] and Examples in Table 1 at paragraph [0084]). Rege teaches that zinc has been shown to have antibacterial properties in plaque and caries studies, and zinc salts have been used in dentifrice compositions (paragraphs [0001]-[0004]); the compositions of Rege are taught to comprise a zinc ion source that provides an amount of zinc effective to inhibit erosion (paragraph [0011]). Rege teaches that the oral care composition can be a toothpaste (paragraph [0048]). Rege teaches that the oral care compositions may include a flavoring agent such as menthol (paragraph [0071]). It would have been prima facie obvious to one of ordinary skill in the art before the effective filing date of the instant invention to substitute the inulin taught by Schapiro for tara gum in the example composition and method of Schapiro. As inulin is expressly stated as a suitable alternative to tara gum in the composition of Schapiro, one of ordinary skill in the art would consider it to have an equivalent effect in the composition. Further, as suggested by Doran, inclusion of inulin in oral care products can be used to maintain a balance of the oral microflora and a reduction of breath odor; as further suggested by Tom’s of Maine, inulin can be used in combination with thickeners in prebiotic toothpaste formulations that help support good bacteria and freshen breath. Substituting inulin into the compositions of Schapiro would therefore predictably result in a toothpaste composition which is effective at maintaining a balance of oral microflora and reducing breath odor. It would further have been prima facie obvious to one of ordinary skill in the art before the effective filing date of the instant invention to incorporate a zinc ion source of zinc citrate in an amount of from about 0.05 to about 5% and a menthol flavoring agent in the toothpaste formulation of Schapiro, as suggested by Rege. One of ordinary skill would have been motivated to do so with a reasonable expectation of success in order to incorporate to an oral composition an agent with antibacterial properties in an amount that is effective to inhibit erosion, and a flavoring agent known to be suitable for use toothpaste formulations, as suggested by Rege. There is a reasonable expectation of success as Schapiro teaches that toothpaste compositions are used to clean and improve the health and aesthetic appearance of the teeth and can comprise flavorants for enhancing the taste and smell sensations when brushing one’s teeth (column 5, lines 50-53), and Tom’s of Maine teaches that zinc citrate can be used in toothpaste formulations in combination with inulin and thickeners such as xanthan gum. Claims 3 and 20 are rejected under 35 U.S.C. 103 as being unpatentable over Schapiro, as evidenced by Deosen, in view of Doran, Tom’s of Maine, and Rege as applied to claims 1-2, 10, 12-15, and 21-32 above and further in view of Teferra (“Possible actions of inulin as prebiotic polysaccharide: A review”, Food Frontiers, published June 15, 2021, 2, 407-416; of record). The teachings of the modified Schapiro are described above. Specifically, regarding instant claims 3 and 20, Schapiro provides in alternative example 2 an example where inulin is present from 0.2-0.7 wt.% and a combination of konjac gum and xanthan/guar are present from 1.15-4.55 wt.%; this provides a range of ratios of fructan to thickening agent from 0.04:1 to 0.6:1. The amount of fructan and weight ratio of fructan and thickening agents overlap the ranges of instant claim 20. From MPEP 2144.05: “In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990).” The combination of Schapiro, Doran, Tom’s of Maine, and Rege do not teach the limitation of instant claim 3 that the inulin comprises a degree of polymerization of from 2 to about 60 or of instant claim 20 that the inulin comprises a degree of polymerization of from 2 to less than 10. Teferra teaches that inulin acts as a prebiotic dietary fiber that stimulates the growth and activities of health beneficial microorganisms (abstract). Teferra further teaches that in plants, inulin naturally exists as a mixture of oligo- and polysaccharides of fructose ranging from 2 to 100 units depending on plant species, age and extraction techniques (pg. 407, “1.1 What is inulin?”). They further teach that the physicochemical and functional properties of inulin are linked to degree of polymerization (DP) and that the short-chain inulin fraction, (oligofructose [OF], DP < 10), is much more soluble and sweeter than native and long-chain inulin, and can contribute to improved mouthfeel (pg. 409, column 1, paragraph 1). Teferra further teaches that the solubility of inulin is dependent on DP, and the solubility of inulin decreases with increase in DP (pg. 409, column 1, paragraph 3). It would have been prima facie obvious to one of ordinary skill in the art before the effective filing date of the instant invention to use inulin with a degree of polymerization of < 10, as taught by Teferra, in the compositions of the modified Schapiro. One of ordinary skill would have been motivated to do so with a reasonable expectation of success in order to use a form of prebiotic inulin that is soluble and has improved mouthfeel, as suggested by Teferra. There is a reasonable expectation of success as Schapiro teaches toothpaste compositions comprising inulin and water, and Doran and Tom’s of Maine further teach inulin for use in prebiotic oral care compositions. Further, MPEP 2144.05: "[i]n the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990)." Response to Arguments Applicants’ arguments filed 03/12/2026 have been fully considered. Regarding the claim rejections under 35 USC § 101, Applicants argue that the present invention does not merely mix natural ingredients; it creates a specific state of matter that resists interaction-induced crystallization. The specification explicitly notes that the formation of precipitates or crystals is the result of the reaction, interaction, or otherwise contact between the one or more fructans and one or more of the remaining ingredients in the presently claimed composition. In nature, inulin does not exist in a stable, aqueous solution containing isolated zinc salts and flavorants such as menthol while remaining resistant to crystallization at temperatures of -10°C. Applicant argues that the claimed combination of fructans, zinc, and thickening agents at a specific ratio creates a thermal stability profile that is entirely absent in the individual components. Because the technical problem is a man-made artifact of the non­natural formulation environment, the solution, a stabilized, non-crystallizing complex, necessarily possesses a non-natural, markedly different functional characteristic. Applicant argues that the amended claims are integrated into a practical application as it is a non-obvious solution to the latent technical problem that the presence of zinc ions and flavorants triggers the formation of unappealing needle-like crystals in prebiotic fructans. The claim provides a specific solution by defining a narrow, man-made weight ratio of fructans to thickening agents (0.1: 1 to about 10: 1.) that inhibits this reaction. These arguments are unpersuasive. The evidence of record does not demonstrate that the claimed combination of one or more thickening agents, one or more fructans, flavorant, and a source of zinc ions has achieved a characteristic that is changed compared to their naturally occurring counterparts. The specification states at paragraph [0077] (emphasis added), “It was surprisingly and unexpected discovered that the inclusion of a thickening agent, namely, xanthan gum, prevented the formation of crystals in the test oral care composition (2).The control oral care composition (2), which excluded the thickening agent, however, exhibited the formation of needle-like crystals. Without being bound by theory, it is believed that the crystal formation is the result of interactions between the inulin and one or more components of the oral care composition, such as, a flavorant (i.e., methanol). It is further believed that the inclusion of the thickening agent resulted in increased viscosity that discouraged the formation of the crystals.” The specification does not provide evidence that these crystals are in fact inulin, or that the crystal formation in the absence of the thickener is the result of interactions between the inulin and one or more components of the composition, but merely presents a hypothesis. The compositions of Table 1 also include approximately 75% water, which is known to freeze at temperatures below 0 °C. As set forth above, xanthan gum is capable of inhibiting the increase of ice crystals at temperatures below 0 °C (as evidence by Deosen). Thus, the Examiner maintains the position that there is no indication of record that the components of the claimed composition have been structurally or functionally changed from their naturally occurring counterparts or that their combination has imparted a markedly different characteristic to the composition. The Examiner further maintains the position that claims do not recite anything else, compositionally or structurally, which provides an inventive concept that departs from merely reciting a composition containing all naturally occurring components, the composition having properties that are consistent with the naturally occurring counterparts of the components of the composition. Regarding the claim rejections under 35 USC § 103, Applicant argues that Rege teaches away from the claimed combination by teaching that zinc formulations are unstable and exhibit significantly less available fluoride unless a basic amino acid is added (citing to paragraphs [0004]-[0005]) and that xanthan gum alone fails to inhibit the formation of zinc fluoride precipitate (citing to Formulation D of Rege). Applicant further argues that the reliance on Deosen to allege that xanthan gum’s function is “latent” is scientifically unsound as Deosen is directed to frozen foods and is non-analogous art; a person having ordinary skill in the art looking to solve “needle-like” crystallization of fructan molecules caused by chemical interactions in a zinc-rich aqueous rinse would not look to the physical management of water-molecule migration in dairy solids. Applicant argues that Rege proves that xanthan gum, acting alone, was entirely unable to stabilize a zinc-comprising dental composition to avoid zinc and fluoride precipitate, and xanthan gum’s properties in dairy rheology are not predictive of its performance in the non-natural, ionic oral care environment claimed. The argument that Rege teaches away from the claimed invention because xanthan gum alone is insufficient to inhibit zinc fluoride precipitate in the absence of arginine is unpersuasive, as neither the instant claims nor the compositions of Schapiro require the presence of fluoride. For the same reason, the argument that Rege proves that xanthan gum is unable to stabilize a zinc-comprising composition to avoid zinc and fluoride precipitation is unpersuasive. The Examiner further notes that the test for obviousness is not whether the features of a secondary reference may be bodily incorporated into the structure of the primary reference; nor is it that the claimed invention must be expressly suggested in any one or all of the references. Rather, the test is what the combined teachings of the references would have suggested to those of ordinary skill in the art. See In re Keller, 642 F.2d 413, 208 USPQ 871 (CCPA 1981). Here, as set forth in the above rejections, Rege teaches the antibacterial and erosion-inhibiting benefits of a zinc ion source, such as zinc citrate, in oral care compositions such as toothpastes, providing motivation to the skilled artisan to include it in the toothpaste formulations of Schapiro. Further, Tom’s of Maine teaches the use of zinc citrate in toothpaste formulations in combination with inulin and thickeners such as xanthan gum. The Examiner therefore respectfully maintains that the combined teachings of the references would have suggested the instantly claimed oral care composition to one of ordinary skill in the art. Regarding Deosen, the Examiner notes that Deosen is relied upon merely as an evidentiary reference that discusses the cold temperature crystal inhibition properties of the xanthan gum. As set forth above, the structural components of the claimed oral care compositions, including xanthan gum, are rendered obvious by the prior art of the modified Schapiro. Absent evidence to the contrary, the physical properties of preventing interaction-induced crystallization of one or more fructans upon exposure to an accelerated aging condition of temperatures at about 0 °C or less as claimed would necessarily follow, regardless of whether that property is explicitly taught in the prior art, as a chemical composition and its properties are inseparable. Applicant further argues that the Examiner’s rejection constitutes impermissible hindsight because it uses the Applicant’s specific identification of the interaction-induced crystallization problem as a template to select and bridge disparate elements from Schapiro, Rege, and Deosen. The motivation to combine these specific ingredients to solve a cold-temperature stability issue of a zinc comprising composition is found only in the Applicant’s own specification. Applicant further argues that modifying Schapiro to incorporate the fluid vehicle and claimed fructan-to-thickener ratios would render the toothpaste unsuitable for its intended purpose. Applicant argues that the surprising and unexpected results in Table 1 further confirms a non-obvious technical improvement of the presently claimed invention over the prior art. In response to applicant's argument that the examiner's conclusion of obviousness is based upon improper hindsight reasoning, it must be recognized that any judgment on obviousness is in a sense necessarily a reconstruction based upon hindsight reasoning. But so long as it takes into account only knowledge which was within the level of ordinary skill at the time the claimed invention was made, and does not include knowledge gleaned only from the applicant's disclosure, such a reconstruction is proper. See In re McLaughlin, 443 F.2d 1392, 170 USPQ 209 (CCPA 1971). The Examiner submits that, as set forth above, the prior art provides motivation and a reasonable expectation of success in arriving at the structural components of the claimed composition in order to reach a toothpaste composition which is effective at maintaining a balance of oral microflora, reducing breath odor, and inhibiting erosion, and that these teachings were within the level of ordinary skill before the effective filing date of the instant invention. The teachings of the prior art render obvious the structural components of the claimed oral care compositions with ranges of inulin, thickening agents, and ratios between the two overlapping those instantly claimed. The argument that incorporating a fluid vehicle and claimed fructan-to-thickener ratios would render the toothpaste of Schapiro unsuitable for its intended purpose is unpersuasive because, as set forth above, Schapiro exemplifies compositions comprising water (a fluid vehicle) and ratios overlapping those of the instant claims. Regarding the argument that the instant invention achieves unexpected results, the Examiner respectfully maintains the position of the Office Action mailed 12/12/2025 that the evidence of record in not commensurate in scope with the instant claims (see MPEP 716.02(d)). In summary, the evidence of record (see Table 1 of the specification) demonstrates a single combination of xanthan gum and inulin, a single concentration of zinc, and a single 1:1 ratio of xanthan gum to inulin; independent claim 1 is much broader in scope, inclusive of the combination of any one or more fructans with any one or more thickening agents in a ratio of from about 0.1:1 to about 10:1. The evidence of record is not commensurate in scope with the claimed invention. In view of the forgoing, and as further detailed in the above rejections, the Examiner maintains that the instant claims are rendered prima facie obvious over the teachings of the modified Schapiro. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JUDITH M KAMM whose telephone number is (703)756-4575. The examiner can normally be reached M-F 8:00 am-4:30 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bethany Barham can be reached at (571)272-6175. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BETHANY P BARHAM/Supervisory Patent Examiner, Art Unit 1611 /J.M.K./Examiner, Art Unit 1611
Read full office action

Prosecution Timeline

Show 10 earlier events
Oct 09, 2024
Non-Final Rejection mailed — §101, §103, §112
Jan 08, 2025
Response Filed
Apr 09, 2025
Final Rejection mailed — §101, §103, §112
Jul 09, 2025
Request for Continued Examination
Jul 15, 2025
Response after Non-Final Action
Dec 12, 2025
Non-Final Rejection mailed — §101, §103, §112
Mar 12, 2026
Response Filed
May 27, 2026
Final Rejection mailed — §101, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12691131
LIPOSOMAL FORMULATIONS, AND METHODS OF USING AND PREPARING THEREOF
4y 10m to grant Granted Jul 28, 2026
Patent 12685316
METHOD OF PREPARING A BISMUTH SULFIDE PARTICLE CONTAINING ANTIBACTERIAL COMPOSITION
3y 2m to grant Granted Jul 21, 2026
Patent 12667533
ALDEHYDE-MODIFIED HYALURONIC ACID, METHOD FOR PREPARING SAME AND APPLICATIONS THEREOF
5y 0m to grant Granted Jun 30, 2026
Patent 12643859
PYRIDYL OXYCARBOXYLIC ACID OXIME DERIVATIVE AND PREPARATION METHOD THEREFOR, WEEDING COMPOSITION AND APPLICATION THEREOF
4y 11m to grant Granted Jun 02, 2026
Patent 12636373
Prodrugs with a tridentate self-immolative linker
4y 11m to grant Granted May 26, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

7-8
Expected OA Rounds
46%
Grant Probability
99%
With Interview (+59.4%)
3y 11m (~2m remaining)
Median Time to Grant
High
PTA Risk
Based on 59 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month